Intercept Pharmaceuticals, Inc. et al v. Apotex Inc. et al > Documents

Date Field	Doc. No.	Description (Pages)
Mar 8, 2023	338	REDACTED VERSION of 327 Letter, by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A- F)(Gaza, Anne) (Entered: 03/08/2023) (Main Document) (2)
Mar 8, 2023	339	REDACTED VERSION of 329 Letter, by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Cucuzzella, Lucinda) (Entered: 03/08/2023) (2)
Mar 8, 2023	338	REDACTED VERSION of 327 Letter, by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A- F)(Gaza, Anne) (Entered: 03/08/2023) (Exhibit A- F) (21)
Mar 1, 2023	337	STIPULATION TO EXTEND TIME for the parties to file public versions of Defendants' Letter to the Court (D.I. 327) and Plaintiffs' Response (D.I. 329) to March 8, 2023 - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Cucuzzella, Lucinda) (Entered: 03/01/2023) (2)
Feb 27, 2023	336	Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Consent Judgment)(mdb) (Entered: 02/27/2023) (Main Document) (1)
Feb 27, 2023	336	Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Consent Judgment)(mdb) (Entered: 02/27/2023) (Consent Judgment) (3)
Feb 24, 2023	332	PROPOSED CONSENT JUDGMENT (Between Plaintiffs and Apotex Defendants) by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 2/24/2023 (dlw). (Entered: 02/24/2023) (3)
Feb 24, 2023	333	CONSENT JUDGMENT (between Plaintiffs and Apotex Defendants). Party Apotex Corp. and Apotex Inc. terminated. Attorney Kevin M. Nelson; Eve H. Ormerod; Sailesh K. Patel; Joel M. Wallace; Matthew T. Wilkerson; Neal C. Belgam and Helen H. Ji terminated as to these Defendants. Signed by Judge Maryellen Noreika on 2/24/2023. (dlw) (Entered: 02/24/2023) (3)
Feb 24, 2023	334	PROPOSED CONSENT JUDGMENT (Between Plaintiffs and MSN Defendants) by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 2/24/2023 (dlw). (Entered: 02/24/2023) (3)
Feb 24, 2023	335	CONSENT JUDGMENT (between Plaintiffs and MSN Defendants). ***Civil Case Terminated. Signed by Judge Maryellen Noreika on 2/24/2023. (dlw) (Entered: 02/24/2023) (3)
Feb 23, 2023	328	Official Transcript of Pretrial Conference held on 2/14/23 before Judge Maryellen Noreika. Court Reporter Dale Hawkins,Email: Dale_Hawkins@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 3/16/2023. Redacted Transcript Deadline set for 3/27/2023. Release of Transcript Restriction set for 5/24/2023. (Triozzi, Heather) (Entered: 02/23/2023) (0)
Feb 23, 2023	329	[SEALED] Letter to The Honorable Maryellen Noreika from Jeremy A. Tigan regarding Response to Defendants' Request for Clarification of the Court's February 14, 2023 Ruling on Plaintiffs' Motion in Limine No. 3 - re 327 Letter,. (Tigan, Jeremy) (Entered: 02/23/2023) (0)
Feb 23, 2023	330	Letter to The Honorable Maryellen Noreika from Eve H. Ormerod regarding Reduction of Claims & Defenses and Order of Presentation at Trial. (Ormerod, Eve) (Entered: 02/23/2023) (2)
Feb 23, 2023	331	ORDER AFTER PRETRIAL CONFERENCE - IT IS HEREBY ORDERED that the Proposed Pretrial Order is ADOPTED as modified by any discussion at the Pretrial Conference as well as the parties' agreements in their February 23, 2023 letter. (See D.I. 328 & 330). Defendants' Letter Regarding Request for Bifurcation of Trial (D.I. 314) is DENIED; Plaintiffs' Motion in Limine No. 1 (D.I. 302, Ex. 14.1) is GRANTED; Plaintiffs' Motion in Limine No. 2 (D.I. 302, Ex. 14.2) is DENIED as moot; Plaintiffs' Motion in Limine No. 3 (D.I. 303, Ex. 14.3) is GRANTED; Defendants' Motion in Limine No. 1 (D.I. 303, Ex. 15.1) is DENIED as moot; and Defendants' Motion in Limine No. 2 (D.I. 303, Ex. 15.2) is DENIED. (See D.I. 328 at 4:5-43:18). SEE ORDER FOR FURTHER AND COMPLETE DETAILS. Signed by Judge Maryellen Noreika on 2/23/2023. (dlw) (Entered: 02/23/2023) (3)
Feb 22, 2023	325	STIPULATION and [Proposed] Order Regarding Infringement (Between Plaintiffs and Apotex Defendants) by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 2/22/2023 (dlw). (Entered: 02/22/2023) (4)
Feb 22, 2023	326	SO ORDERED re 325 Stipulation and Order Regarding Infringement (between Plaintiffs and Apotex Defendants). Signed by Judge Maryellen Noreika on 2/22/2023. (dlw) (Entered: 02/22/2023) (4)
Feb 22, 2023	327	[SEALED] Letter to The Honorable Maryellen Noreika from Anne Shea Gaza regarding Defendants' request for clarification of the Court's oral order granting Plaintiffs' motion in limine no. 3. (Attachments: # 1 Exhibit A - F)(Gaza, Anne) (Entered: 02/22/2023) (0)
Feb 21, 2023	322	SO ORDERED re 321 Stipulation and Order Regarding Infringement (between Plaintiffs and MSN Defendants). Signed by Judge Maryellen Noreika on 2/21/2023. (dlw) (Entered: 02/21/2023) (5)
Feb 21, 2023	323	PROPOSED CONSENT JUDGMENT (Between Plaintiffs and Lupin Defendants) by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 2/21/2023 (dlw). (Entered: 02/21/2023) (3)
Feb 21, 2023	324	CONSENT JUDGMENT (between Plaintiffs and Lupin Defendants). Party Lupin Limited and Lupin Pharmaceuticals, Inc. terminated. Attorney Wojciech K. Jankiewicz; Joseph M. Janusz; Jitendra M. Malik; Deepro R. Mukerjee; Deepro R. Mukerjee; Deepro R. Mukerjee; John C. Phillips, Jr; Lance A. Soderstrom; Megan C. Haney and Matthew M. Holub terminated as to Lupin Defendants. Signed by Judge Maryellen Noreika on 2/21/2023. (dlw) (Entered: 02/21/2023) (3)
Feb 17, 2023	321	STIPULATION and [Proposed] Order Regarding Infringement (Between Plaintiffs and MSN Defendants) by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) Modified on 2/17/2023 (mdb). (Entered: 02/17/2023) (5)
Feb 15, 2023	320	Letter to The Honorable Maryellen Noreika from Jeremy A. Tigan regarding Intercept's Live Fact Witness. (Tigan, Jeremy) (Entered: 02/15/2023) (1)
Feb 10, 2023	319	Letter to The Honorable Maryellen Noreika from Jeremy A. Tigan regarding Intercept's response to Apotex's request for bifurcation of trial - re 314 Letter. (Tigan, Jeremy) (Entered: 02/10/2023) (2)
Feb 9, 2023	318	NOTICE of Withdrawal of Joint Notice of Intent to Redact by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. re 317 Notice (Other) (Cucuzzella, Lucinda) Modified on 2/10/2023 (dlw). (Entered: 02/09/2023) (2)
Jan 30, 2023	316	NOTICE OF SERVICE of Defendants' Notice Pursuant to 35 U.S.C. � 282 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Wilson, Samantha) (Entered: 01/30/2023) (2)
Jan 30, 2023	317	Joint NOTICE of Intent to Redact Transcript by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. re Discovery Conference, 296 Transcript,, (Cucuzzella, Lucinda) (Entered: 01/30/2023) (2)
Jan 27, 2023	314	Letter to The Honorable Maryellen Noreika from Eve H. Ormerod regarding Request for Bifurcation of Trial. (Ormerod, Eve) (Entered: 01/27/2023) (2)
Jan 27, 2023	315	NOTICE OF SERVICE of Supplemental Expert Report of Laird Forrest, Ph.D. filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Wilson, Samantha) (Entered: 01/27/2023) (2)
Jan 26, 2023	310	REDACTED VERSION of 300 Proposed Pretrial Order Volume 1 of 4 by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-3)(Tigan, Jeremy) Modified on 1/27/2023 (mdb). (Entered: 01/26/2023) (Main Document) (30)
Jan 26, 2023	311	REDACTED VERSION of 301 Proposed Pretrial Order Volume 2 of 4 by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 4-10)(Tigan, Jeremy) Modified on 1/27/2023 (mdb). (Entered: 01/26/2023) (Main Document) (1)
Jan 26, 2023	312	REDACTED VERSION of 302 Proposed Pretrial Order Volume 3 of 4 by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 11-14.2)(Tigan, Jeremy) Modified on 1/27/2023 (mdb). (Entered: 01/26/2023) (Main Document) (1)
Jan 26, 2023	313	REDACTED VERSION of 303 Proposed Pretrial Order Volume 4 of 4 by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 14.3-15.2)(Tigan, Jeremy) Modified on 1/27/2023 (mdb). (Entered: 01/26/2023) (Main Document) (1)
Jan 26, 2023	313	REDACTED VERSION of 303 Proposed Pretrial Order Volume 4 of 4 by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 14.3-15.2)(Tigan, Jeremy) Modified on 1/27/2023 (mdb). (Entered: 01/26/2023) (Exhibits 14.3-15.2) (30)
Jan 26, 2023	310	REDACTED VERSION of 300 Proposed Pretrial Order Volume 1 of 4 by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-3)(Tigan, Jeremy) Modified on 1/27/2023 (mdb). (Entered: 01/26/2023) (Exhibits 1-3) (30)
Jan 26, 2023	311	REDACTED VERSION of 301 Proposed Pretrial Order Volume 2 of 4 by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 4-10)(Tigan, Jeremy) Modified on 1/27/2023 (mdb). (Entered: 01/26/2023) (Exhibits 4-10) (30)
Jan 26, 2023	312	REDACTED VERSION of 302 Proposed Pretrial Order Volume 3 of 4 by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 11-14.2)(Tigan, Jeremy) Modified on 1/27/2023 (mdb). (Entered: 01/26/2023) (Exhibits 11-14.2) (30)
Jan 25, 2023	308	PROPOSED CONSENT JUDGMENT (between Plaintiffs and Amneal defendants) by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 1/25/2023 (dlw). (Entered: 01/25/2023) (3)
Jan 25, 2023	309	CONSENT JUDGMENT (between Plaintiffs and Amneal Defendants). Party Amneal EU, Limited and Amneal Pharmaceuticals of New York, LLC terminated. Attorney Anne Shea Gaza; Samantha G. Wilson; Bryce A. Cooper and Claire A. Fundakowski terminated as to these Defendants. Signed by Judge Maryellen Noreika on 1/25/2023. (dlw) (Entered: 01/25/2023) (3)
Jan 24, 2023	307	STIPULATION TO EXTEND TIME to file a redacted version of the Joint [Proposed] Pretrial Order (D.I. 300-303) to January 26, 2023 - filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Wilson, Samantha) (Entered: 01/24/2023) (2)
Jan 17, 2023	304	PROPOSED CONSENT JUDGMENT (Between Plaintiffs and Optimus Defendants) by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 1/17/2023 (dlw). (Entered: 01/17/2023) (3)
Jan 17, 2023	305	CONSENT JUDGMENT (between Intercept and Optimus Defendants). Party Optimus Drugs Private Ltd. and Optimus Pharma Pvt. Ltd. terminated. Attorney Michael P. Hogan and R. Touhey Myer terminated. Signed by Judge Maryellen Noreika on 1/17/2023. (dlw) (Entered: 01/17/2023) (3)
Jan 17, 2023	306	STIPULATION TO EXTEND TIME for the parties to file a redacted version of the Joint [Proposed] Pretrial Order (D.I. 300-303) to January 24, 2023 - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/17/2023) (2)
Jan 10, 2023	297	REDACTED VERSION of 289 Letter by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Attachments: # 1 Exs. A-I)(Tigan, Jeremy) (Entered: 01/10/2023) (Main Document) (5)
Jan 10, 2023	298	REDACTED VERSION of 288 Defendants' Opposition to Plaintiffs' Motion to Strike by Apotex Corp., Apotex Inc. (Ormerod, Eve) Modified on 1/11/2023 (ceg). (Entered: 01/10/2023) (5)
Jan 10, 2023	299	REDACTED VERSION of 290 Exhibits 1 - 8 of Defendants' Opposition to Plaintiffs' Motion to Strike by Apotex Corp., Apotex Inc. (Ormerod, Eve) Modified on 1/11/2023 (ceg). (Entered: 01/10/2023) (2)
Jan 10, 2023	300	[SEALED] Proposed Pretrial Order -- Volume 1 of 4 -- by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Attachments: # 1 Exhibits 1-3)(Tigan, Jeremy) Modified on 1/11/2023 (dlw). (Entered: 01/10/2023) (0)
Jan 10, 2023	301	[SEALED] Proposed Pretrial Order -- Volume 2 of 4 -- by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Attachments: # 1 Exhibits 4-10)(Tigan, Jeremy) Modified on 1/11/2023 (dlw). (Entered: 01/10/2023) (0)
Jan 10, 2023	302	[SEALED] Proposed Pretrial Order -- Volume 3 of 4 -- by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Attachments: # 1 Exhibits 11-14.2)(Tigan, Jeremy) Modified on 1/11/2023 (dlw). (Entered: 01/10/2023) (0)
Jan 10, 2023	303	[SEALED] Proposed Pretrial Order -- Volume 4 of 4 -- by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Attachments: # 1 Exhibits 14.3-15.2)(Tigan, Jeremy) Modified on 1/11/2023 (dlw). (Entered: 01/10/2023) (0)
Jan 10, 2023	297	REDACTED VERSION of 289 Letter by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Attachments: # 1 Exs. A-I)(Tigan, Jeremy) (Entered: 01/10/2023) (Exs. A-I) (13)
Jan 9, 2023	296	Official Transcript of Teleconference held on 12/29/2022 before Judge Jennifer L. Hall. Court Reporter/Transcriber Dale C. Hawkins,Email: Dale_Hawkins@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/30/2023. Redacted Transcript Deadline set for 2/9/2023. Release of Transcript Restriction set for 4/10/2023. (dh) (Entered: 01/09/2023) (0)
Jan 6, 2023	295	Joint Letter to The Honorable Jennifer L. Hall from Jeremy A. Tigan regarding outstanding discovery disputes. (Tigan, Jeremy) (Entered: 01/06/2023) (1)
Jan 5, 2023	293	REDACTED VERSION of 286 Letter by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Attachments: # 1 Exs. 1-8)(Tigan, Jeremy) (Entered: 01/05/2023) (Main Document) (4)
Jan 5, 2023	294	REDACTED VERSION of 287 Letter by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Gaza, Anne) (Entered: 01/05/2023) (30)
Jan 5, 2023	293	REDACTED VERSION of 286 Letter by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Attachments: # 1 Exs. 1-8)(Tigan, Jeremy) (Entered: 01/05/2023) (Exs. 1-8) (29)
Dec 30, 2022	291	STIPULATION TO EXTEND TIME to file redacted versions of parties' opening discovery dispute letters (D.I. 287-88) and responsive discovery dispute letters (D.I. 289-90) to January 5 and 10, 2023 - filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Wilson, Samantha) (Entered: 12/30/2022) (2)
Dec 30, 2022	292	ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the December 29, 2022 discovery dispute teleconference shall serve as the Order of the Court. ORDERED by Judge Jennifer L. Hall on 12/29/2022. (ceg) (Entered: 12/30/2022) (0)
Dec 27, 2022	288	[SEALED] Letter to The Honorable Jennifer L. Hall from Eve H. Ormerod regarding Defendants' Opposition to Plaintiffs' Motion to Strike - re 286 Letter. (Ormerod, Eve) (Entered: 12/27/2022) (0)
Dec 27, 2022	289	[SEALED] Letter to The Honorable Jennifer L. Hall from Jeremy A. Tigan regarding Opposition to Defendants' Motion to Compel. (Attachments: # 1 Exs. A-I)(Tigan, Jeremy) (Entered: 12/27/2022) (0)
Dec 27, 2022	290	[SEALED] EXHIBIT re 288 Letter Exhibits 1 - 8 of Defendants' Opposition to Plaintiffs' Motion to Strike, with Certificate of Service by Apotex Corp., Apotex Inc.. (Ormerod, Eve) (Entered: 12/27/2022) (0)
Dec 22, 2022	286	[SEALED] Letter to the Honorable Jennifer L. Hall from Jeremy A. Tigan regarding Motion to Strike. (Attachments: # 1 Proposed Order, # 2 Exs. 1-8)(Tigan, Jeremy) (Entered: 12/22/2022) (0)
Dec 22, 2022	287	[SEALED] Letter to The Honorable Jennifer L. Hall from Anne Shea Gaza regarding Defendants' motion to compel - re 285 Order Setting Teleconference,,,,. (Attachments: # 1 Exhibit 1 - 23)(Gaza, Anne) (Entered: 12/22/2022) (0)
Dec 21, 2022	285	ORAL ORDER Setting Teleconference: The Court has reviewed the Joint Motion for Teleconference to Resolve Discovery Dispute (D.I. 281 ). A discovery dispute teleconference is scheduled for December 29, 2022 at 4:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than December 22, 2022, the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than December 27, 2022, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 12/21/2022. (ceg) (Entered: 12/21/2022) (0)
Dec 19, 2022	282	NOTICE to Take Deposition of Ivan Hofmann on December 20, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 12/19/2022) (6)
Dec 19, 2022	283	NOTICE to Take Deposition of Christine S. Meyer, Ph.D. on December 20, 2022 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 12/19/2022) (2)
Dec 19, 2022	284	NOTICE to Take Deposition of Dr. Steven Baldwin on December 21, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 12/19/2022) (6)
Dec 15, 2022	281	Joint MOTION for Teleconference to Resolve Discovery Dispute - filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. (Wilson, Samantha) Modified on 12/16/2022 (ceg). (Entered: 12/15/2022) (3)
Dec 12, 2022	276	NOTICE to Take Deposition of Dr. Allan S. Myerson on December 16, 2022 filed by Apotex Corp., Apotex Inc..(Ormerod, Eve) (Entered: 12/12/2022) (2)
Dec 12, 2022	277	ORAL ORDER - Consistent with the Scheduling Order, the parties contacted Chambers to request a teleconference date for expert discovery disputes, IT IS HEREBY ORDERED that these disputes are referred to Magistrate Judge Hall. The parties are directed to file Magistrate Judge Hall's "Motion for Teleconference to Resolve Discovery/Protective Order Disputes" which can be found at https://www.ded.uscourts.gov/judge/magistrate-judge-jennifer-l-hall, forms. ORDERED by Judge Maryellen Noreika on 12/12/2022. (dlw) (Entered: 12/12/2022) (0)
Dec 12, 2022	278	NOTICE to Take Deposition of Dr. Stephen Byrn on December 14, 2022 filed by Apotex Corp., Apotex Inc..(Ormerod, Eve) (Entered: 12/12/2022) (2)
Dec 12, 2022	279	NOTICE to Take Deposition of Dr. Laird Forrest on December 13, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 12/12/2022) (6)
Dec 12, 2022	280	NOTICE to Take Deposition of Dr. Maureen Donovan on December 14, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 12/12/2022) (6)
Dec 7, 2022	274	NOTICE to Take Deposition of Dr. Cory J. Berkland on December 8, 2022 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 12/07/2022) (2)
Dec 7, 2022	275	NOTICE to Take Deposition of Dr. William Dichtel on December 9, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 12/07/2022) (6)
Dec 6, 2022	273	NOTICE to Take Deposition of Dr. David E. Bernstein on December 8, 2022 filed by Apotex Corp., Apotex Inc..(Ormerod, Eve) (Entered: 12/06/2022) (2)
Dec 2, 2022	270	NOTICE to Take Deposition of Dr. Phil S. Baran on December 7, 2022 filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Wilson, Samantha) (Entered: 12/02/2022) (4)
Dec 2, 2022	271	NOTICE to Take Deposition of Dr. Ravi Natarajan on December 2, 2022 filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Wilson, Samantha) (Entered: 12/02/2022) (4)
Dec 2, 2022	272	NOTICE to Take Deposition of Dr. Josh Levitsky, M.D., M.S. on December 6, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 12/02/2022) (6)
Nov 23, 2022	269	NOTICE to Take Deposition of Dr. Stephen H. Spiegelberg on November 29, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 11/23/2022) (6)
Nov 17, 2022	267	NOTICE OF SERVICE of (1) Reply Expert Report of David Bernstein, M.D. Regarding Objective Indicia of Nonobviousness of U.S. Patent No. RE48,286; (2) Expert Reply Report of Christine S. Meyer, Ph.D.; (3) Reply Expert Report of Paul J. Reider, Ph.D. Regarding Objective Indicia of Non-Obviousness Supporting the Validity of U.S. Patent No. RE48,286 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 11/17/2022) (8)
Nov 17, 2022	268	NOTICE OF SERVICE of (1) Reply Expert Report of Cory J. Berkland, Ph.D. Regarding Testing of Apotex's Samples; (2) Reply Expert Report of Dr. Stephen Byrn Regarding Testing of Apotex's Samples; (3) Reply Expert Report of Dr. Allan Myerson Regarding Apotex's Infringement of U.S. Patent No. 10,052,337 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 11/17/2022) (3)
Nov 16, 2022	266	NOTICE OF SERVICE of Defendants' 1) Reply Expert Report of Steven W. Baldwin, Ph.D., with exhibits, 2) Reply Expert Report of William Dichtel, Ph.D., with exhibits, 3) Reply Expert Report of Maureen Donovan, Ph.D., 4) Reply Expert Report of Laird Forrest, Ph.D., with exhibits, and 5) Reply Expert Report of Joshua Levitsky, M.D., M.S. filed by Apotex Corp., Apotex Inc..(Ormerod, Eve) (Entered: 11/16/2022) (2)
Oct 24, 2022	265	NOTICE OF SERVICE of (1) Rebuttal Expert Report of Paul J. Reider, Ph.D. Regarding the Validity of U.S. Patent No. RE48,286; (2) Rebuttal Expert Report of Dr. Phil S. Baran Regarding Validity & Enforceability of U.S. Patent Nos. 9,238,673; 10,047,117; and 10,174,073; (3) Expert Report of Dr. Ravi Natarajan Regarding Synthesis and Testing on Obeticholic Acid; (4) Rebuttal Expert Report of Cory J. Berkland, Ph.D. Regarding U.S. Patent Nos. 10,052,337; 10,751,349; and 10,758,549; and (5) Rebuttal Expert Report of David Bernstein, M.D. Regarding U.S. Patent No. 10,758,549 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 10/24/2022) (8)
Oct 21, 2022	264	NOTICE OF SERVICE of Defendants Responsive Expert Reports of William Dichtel, Ph.D., Ivan T. Hofmann, and Joshua Levitsky, M.D., M.S., and Apotex Inc. and Apotex Corp.s Responsive Expert Report of Stephen H. Spiegelberg, Ph.D filed by Apotex Corp., Apotex Inc..(Ormerod, Eve) (Entered: 10/21/2022) (1)
Sep 30, 2022	259	REDACTED VERSION of 254 Answer to Complaint by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 10/3/2022 (dlw). (Entered: 09/30/2022) (30)
Sep 30, 2022	260	REDACTED VERSION of 255 Answer to Counterclaim by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 09/30/2022) (30)
Sep 30, 2022	261	REDACTED VERSION of 256 Answer to Counterclaim by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 09/30/2022) (30)
Sep 30, 2022	262	REDACTED VERSION of 257 Answer to Counterclaim by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 09/30/2022) (30)
Sep 30, 2022	263	REDACTED VERSION of 258 Answer to Counterclaim by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 09/30/2022) (30)
Sep 23, 2022	254	[SEALED] ANSWER to 236 Apotex Inc. and Apotex Corp.'s First Amended Answer to Second Amended Complaint, Separate Defenses, and Counterclaims by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) Modified on 9/26/2022 (mdb). (Entered: 09/23/2022) (0)
Sep 23, 2022	255	[SEALED] ANSWER to 231 Amended Answer to Complaint,, Counterclaim, by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 09/23/2022) (0)
Sep 23, 2022	256	[SEALED] ANSWER to 233 Answer to Amended Complaint,, Counterclaim, by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 09/23/2022) (0)
Sep 23, 2022	257	[SEALED] ANSWER to 232 Amended Answer to Complaint,, Counterclaim, by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 09/23/2022) (0)
Sep 23, 2022	258	[SEALED] ANSWER to 237 Answer to Amended Complaint,, Counterclaim, by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 09/23/2022) (0)
Sep 16, 2022	251	REDACTED VERSION of 233 Answer to Amended Complaint,, Counterclaim, by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-40, # 2 Exhibits 41-45, # 3 Exhibits 46-50, # 4 Exhibits 51-55)(Haney, Megan) (Entered: 09/16/2022) (Main Document) (30)
Sep 16, 2022	252	REDACTED VERSION of 232 Amended Answer to Complaint,, Counterclaim, by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1 - 55)(Gaza, Anne) (Entered: 09/16/2022) (Main Document) (30)
Sep 16, 2022	253	REDACTED VERSION of 231 Amended Answer to Complaint,, Counterclaim, by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC. (Attachments: # 1 Exhibit 1 - 55)(Gaza, Anne) (Entered: 09/16/2022) (Main Document) (30)
Sep 16, 2022	253	REDACTED VERSION of 231 Amended Answer to Complaint,, Counterclaim, by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC. (Attachments: # 1 Exhibit 1 - 55)(Gaza, Anne) (Entered: 09/16/2022) (Exhibit 1 - 55) (30)
Sep 16, 2022	251	REDACTED VERSION of 233 Answer to Amended Complaint,, Counterclaim, by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-40, # 2 Exhibits 41-45, # 3 Exhibits 46-50, # 4 Exhibits 51-55)(Haney, Megan) (Entered: 09/16/2022) (Exhibits 1-40) (30)
Sep 16, 2022	251	REDACTED VERSION of 233 Answer to Amended Complaint,, Counterclaim, by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-40, # 2 Exhibits 41-45, # 3 Exhibits 46-50, # 4 Exhibits 51-55)(Haney, Megan) (Entered: 09/16/2022) (Exhibits 41-45) (1)
Sep 16, 2022	251	REDACTED VERSION of 233 Answer to Amended Complaint,, Counterclaim, by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-40, # 2 Exhibits 41-45, # 3 Exhibits 46-50, # 4 Exhibits 51-55)(Haney, Megan) (Entered: 09/16/2022) (Exhibits 46-50) (1)
Sep 16, 2022	251	REDACTED VERSION of 233 Answer to Amended Complaint,, Counterclaim, by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-40, # 2 Exhibits 41-45, # 3 Exhibits 46-50, # 4 Exhibits 51-55)(Haney, Megan) (Entered: 09/16/2022) (Exhibits 51-55) (16)
Sep 16, 2022	252	REDACTED VERSION of 232 Amended Answer to Complaint,, Counterclaim, by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1 - 55)(Gaza, Anne) (Entered: 09/16/2022) (Exhibit 1 - 55) (30)
Sep 14, 2022	248	NOTICE OF SERVICE of (1) Opening Expert Report of David Bernstein, M.D., Regarding Optimus's Infringement of U.S. Patent Nos. 10,047,117 and 10,758,549, (2) Opening Expert Report of Dr. Stephen Byrn Regarding Testing of Optimus Samples and (3) Opening Expert Report of Dr. Allan S. Myerson Regarding Optimus's Infringement of U.S. Patent Nos. RE48,286; 9,238,673; 10,174,073; 10,047,117; 10,052,337; and 10,758,549 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 09/14/2022) (6)
Sep 14, 2022	249	STIPULATION TO EXTEND TIME for Plaintiffs to move, answer, or otherwise respond to Defendants' First Amended Answers and Counterclaims (D.I. 231-233, 236-237) to September 23, 2022 - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 09/14/2022) (2)
Sep 14, 2022	250	REDACTED VERSION of 229 Letter, by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Defendants' Final Invalidity Contentions)(Wilson, Samantha) (Entered: 09/14/2022) (Main Document) (1)
Sep 14, 2022	250	REDACTED VERSION of 229 Letter, by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Defendants' Final Invalidity Contentions)(Wilson, Samantha) (Entered: 09/14/2022) (Defendants' Final Invalidity Contentions) (30)
Sep 13, 2022	246	REDACTED VERSION of 236 Amended Answer to Complaint by Apotex Corp., Apotex Inc.. (Attachments: # 1 Exhibit 1 - 52)(Ormerod, Eve) (Entered: 09/13/2022) (Main Document) (30)
Sep 13, 2022	247	REDACTED VERSION of 237 Answer to Amended Complaint,, Counterclaim, by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd.. (Attachments: # 1 Exhibit 1-25, # 2 Exhibit 26-40, # 3 Exhibit 41-48, # 4 Exhibit 49-52, # 5 Certificate of Service)(Myer, R.) (Entered: 09/13/2022) (Main Document) (30)
Sep 13, 2022	246	REDACTED VERSION of 236 Amended Answer to Complaint by Apotex Corp., Apotex Inc.. (Attachments: # 1 Exhibit 1 - 52)(Ormerod, Eve) (Entered: 09/13/2022) (Exhibit 1 - 52) (30)
Sep 13, 2022	247	REDACTED VERSION of 237 Answer to Amended Complaint,, Counterclaim, by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd.. (Attachments: # 1 Exhibit 1-25, # 2 Exhibit 26-40, # 3 Exhibit 41-48, # 4 Exhibit 49-52, # 5 Certificate of Service)(Myer, R.) (Entered: 09/13/2022) (Exhibit 1-25) (30)
Sep 13, 2022	247	REDACTED VERSION of 237 Answer to Amended Complaint,, Counterclaim, by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd.. (Attachments: # 1 Exhibit 1-25, # 2 Exhibit 26-40, # 3 Exhibit 41-48, # 4 Exhibit 49-52, # 5 Certificate of Service)(Myer, R.) (Entered: 09/13/2022) (Exhibit 26-40) (30)
Sep 13, 2022	247	REDACTED VERSION of 237 Answer to Amended Complaint,, Counterclaim, by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd.. (Attachments: # 1 Exhibit 1-25, # 2 Exhibit 26-40, # 3 Exhibit 41-48, # 4 Exhibit 49-52, # 5 Certificate of Service)(Myer, R.) (Entered: 09/13/2022) (Exhibit 41-48) (30)
Sep 13, 2022	247	REDACTED VERSION of 237 Answer to Amended Complaint,, Counterclaim, by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd.. (Attachments: # 1 Exhibit 1-25, # 2 Exhibit 26-40, # 3 Exhibit 41-48, # 4 Exhibit 49-52, # 5 Certificate of Service)(Myer, R.) (Entered: 09/13/2022) (Exhibit 49-52) (30)
Sep 13, 2022	247	REDACTED VERSION of 237 Answer to Amended Complaint,, Counterclaim, by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd.. (Attachments: # 1 Exhibit 1-25, # 2 Exhibit 26-40, # 3 Exhibit 41-48, # 4 Exhibit 49-52, # 5 Certificate of Service)(Myer, R.) (Entered: 09/13/2022) (Certificate of Service) (3)
Sep 12, 2022	240	NOTICE OF SERVICE of Defendants Apotex Inc. and Apotex Corp.'s opening expert report of Josh Levitsky, M.D., M.S., with exhibits, opening expert report of Maureen Donovan, PH.D., opening expert report of Steven W. Baldwin PH.D., with exhibits, and the expert report of William Dichtel, PH.D., with exhibits filed by Apotex Corp., Apotex Inc..(Ormerod, Eve) (Entered: 09/12/2022) (2)
Sep 12, 2022	241	NOTICE OF SERVICE of (1) Opening Expert Report of David Bernstein, M.D. Regarding Amneal's Infringement of U.S. Patent Nos. 10,047,117 and 10,758,549, (2) Opening Expert Report of Dr. Stephen Byrn Regarding Testing of Amneal Samples, (3) Opening Expert Report of Dr. Allan S. Myerson Regarding Amneal's Infringement of U.S. Patent Nos. 9,238,673; 10,047,117; 10,052,337; 10,751,349; and 10,758,549 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 09/12/2022) (6)
Sep 12, 2022	242	NOTICE OF SERVICE of (1) Opening Expert Report of David Bernstein, M.D., Regarding Apotex's Infringement of U.S. Patent Nos. 10,047,117 and 10,758,549, (2) Opening Expert Report of Dr. Stephen Byrn Regarding Testing of Apotex Samples, (3) Opening Expert Report of Dr. Allan S. Myerson Regarding Apotex's Infringement of U.S. Patent Nos. RE48,286; 9,238,673; 10,047,117; 10,052,337; and 10,758,549, (4) Opening Expert Report of Cory J. Berkland, Ph.D. Regarding Testing of Apotex's Samples, (5) Opening Expert Report of David Bernstein, M.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent No. RE48,286, (6) Opening Expert Report of Paul J. Reider, Ph.D. Regarding Objective Indicia of Non-Obviousness Supporting the Validity of U.S. Patent No. RE48,286, (7) Opening Expert Report of Christine S. Meyer, Ph.D. filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 09/12/2022) (6)
Sep 12, 2022	243	NOTICE OF SERVICE of (1) Opening Expert Report of David Bernstein, M.D., Regarding Lupin's Infringement of U.S. Patent Nos. 10,047,117 and 10,758,549, (2) Opening Expert Report of Dr. Stephen Byrn Regarding Testing of Lupin Samples, (3) Opening Expert Report of Dr. Allan S. Myerson Regarding Lupin's Infringement of U.S. Patent Nos. RE48,286; 9,238,673; 10,047,117; 10,052,337; and 10,758,549, (4) Opening Expert Report of David Bernstein, M.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent No. RE48,286, (5) Opening Expert Report of Paul J. Reider, Ph.D. Regarding Objective Indicia of Non-Obviousness Supporting the Validity of U.S. Patent No. RE48,286, (6) Opening Expert Report of Christine S. Meyer, Ph.D. filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 09/12/2022) (7)
Sep 12, 2022	244	NOTICE OF SERVICE of (1) Opening Expert Report of David Bernstein, M.D. Regarding MSN's Infringement of U.S. Patent Nos. 10,047,117 and 10,758,549, (2) Opening Expert Report of Dr. Stephen Byrn Regarding Testing of MSN Samples, (3) Opening Expert Report of Dr. Allan S. Myerson Regarding MSN Infringement of U.S. Patent Nos. RE48,286; 9,238,673; 10,047,117; 10,052,337 and 10,758,549, (4) Opening Expert Report of Cory J. Berkland, Ph.D. Regarding Testing of MSN's Samples, (5) Opening Expert Report of David Bernstein, M.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent No. RE48,286; (6) Expert Report of Christine S. Meyer, Ph.D., (7) Opening Expert Report of Paul J. Reider, Ph.D. Regarding Objective Indicia of Non-Obviousness Supporting the Validity of U.S. Patent No. RE48,286 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 09/12/2022) (7)
Sep 12, 2022	245	NOTICE OF SERVICE of (1) Opening Expert Report of David Bernstein, M.D., Regarding Objective Indicia of Nonobviousness of U.S. Patent No. RE48,286, (2) Expert Report of Christine S. Meyer, Ph.D., (3) Opening Expert Report of Paul J. Reider, Ph.D. Regarding Objective Indicia of Non-Obviousness Supporting the Validity of U.S. Patent No. RE48,286 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 09/12/2022) (6)
Sep 9, 2022	239	STIPULATION TO EXTEND TIME for the Amneal, MSN and Lupin Defendants to file redacted versions of their First Amended Answers and Counterclaims (D.I. 231-233) to Plaintiffs' First Amended Complaints to September 16, 2022 - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 09/09/2022) (2)
Sep 7, 2022	238	STIPULATION TO EXTEND TIME for the Defendants to file a redacted version of their Letter to Judge Hall regarding Final Invalidity Contentions (D.I. 229) to September 14, 2022 - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 09/07/2022) (2)
Sep 6, 2022	234	NOTICE to Take Deposition of Pasula Basavaiah Chowdary on September 9, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 09/06/2022) (3)
Sep 6, 2022	235	REDACTED VERSION of 225 Letter, by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Tigan, Jeremy) (Entered: 09/06/2022) (Main Document) (5)
Sep 6, 2022	236	[SEALED] AMENDED ANSWER to 35 Amended Complaint by Apotex Corp., Apotex Inc.. (Attachments: # 1 Exhibit 1-25, # 2 Exhibit 26-40, # 3 Exhibit 41-48, # 4 Exhibit 49-52 with Certificate of Service)(Ormerod, Eve) (Entered: 09/06/2022) (0)
Sep 6, 2022	237	[SEALED] ANSWER to Amended Complaint, re: 15 Amended Complaint, , COUNTERCLAIM against Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd.. (Attachments: # 1 Exhibit 1-25, # 2 Exhibit 26-40, # 3 Exhibit 41-48, # 4 Exhibit 49-52, # 5 Certificate of Service)(Myer, R.) (Entered: 09/06/2022) (0)
Sep 6, 2022	235	REDACTED VERSION of 225 Letter, by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Tigan, Jeremy) (Entered: 09/06/2022) (Exhibit A) (3)
Sep 6, 2022	235	REDACTED VERSION of 225 Letter, by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Tigan, Jeremy) (Entered: 09/06/2022) (Exhibit B) (23)
Sep 2, 2022	231	[SEALED] AMENDED ANSWER to 15 Amended Complaint,, COUNTERCLAIM against Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. by Amneal Pharmaceuticals of New York, LLC, Amneal EU, Limited. (Attachments: # 1 Exhibit 1 - 25, # 2 Exhibit 26 - 40, # 3 Exhibit 41 - 48, # 4 Exhibit 49 - 55)(Gaza, Anne) (Entered: 09/02/2022) (0)
Sep 2, 2022	232	[SEALED] AMENDED ANSWER to 15 Amended Complaint,, COUNTERCLAIM against Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1 - 25, # 2 Exhibit 26 - 40, # 3 Exhibit 41 - 48, # 4 Exhibit 49 -55)(Gaza, Anne) (Entered: 09/02/2022) (0)
Sep 2, 2022	233	[SEALED] ANSWER to Amended Complaint, re: 15 Amended Complaint, , COUNTERCLAIM against Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. by Lupin Pharmaceuticals, Inc., Lupin Limited. (Attachments: # 1 Exhibit 1-25, # 2 Exhibit 26-40, # 3 Exhibit 41-48, # 4 Exhibit 49-55)(Phillips, John) (Entered: 09/02/2022) (0)
Sep 1, 2022	230	MEMORANDUM ORDER: IT IS ORDERED that Defendants' request for leave to amend their answers and counterclaims is GRANTED. (*See Memorandum Order for details). Signed by Judge Jennifer L. Hall on 9/1/2022. (ceg) (Entered: 09/01/2022) (5)
Aug 31, 2022	226	REDACTED VERSION of 220 Letter,, by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit Volume 1 - Part 1 (A1 and 1 through 40), # 3 Exhibit Volume 1 - Part 2 (41 through 45), # 4 Exhibit Volume 1 - Part 3 (46 through 50))(Wilson, Samantha) (Entered: 08/31/2022) (Main Document) (5)
Aug 31, 2022	227	REDACTED VERSION of 221 Exhibit to a Document by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Wilson, Samantha) (Entered: 08/31/2022) (30)
Aug 31, 2022	228	REDACTED VERSION of 222 Exhibit to a Document by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Wilson, Samantha) (Entered: 08/31/2022) (30)
Aug 31, 2022	229	[SEALED] Letter to The Honorable Jennifer L. Hall from Samantha G. Wilson regarding Final Invalidity Contentions discussed at today's hearing. (Attachments: # 1 Defendants' Final Invalidity Contentions)(Wilson, Samantha) Modified on 9/1/2022 (ceg). (Entered: 08/31/2022) (0)
Aug 31, 2022	226	REDACTED VERSION of 220 Letter,, by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit Volume 1 - Part 1 (A1 and 1 through 40), # 3 Exhibit Volume 1 - Part 2 (41 through 45), # 4 Exhibit Volume 1 - Part 3 (46 through 50))(Wilson, Samantha) (Entered: 08/31/2022) (Text of Proposed Order) (1)
Aug 31, 2022	226	REDACTED VERSION of 220 Letter,, by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit Volume 1 - Part 1 (A1 and 1 through 40), # 3 Exhibit Volume 1 - Part 2 (41 through 45), # 4 Exhibit Volume 1 - Part 3 (46 through 50))(Wilson, Samantha) (Entered: 08/31/2022) (Exhibit Volume 1 - Part 1 (A1 and 1 through 40)) (30)
Aug 31, 2022	226	REDACTED VERSION of 220 Letter,, by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit Volume 1 - Part 1 (A1 and 1 through 40), # 3 Exhibit Volume 1 - Part 2 (41 through 45), # 4 Exhibit Volume 1 - Part 3 (46 through 50))(Wilson, Samantha) (Entered: 08/31/2022) (Exhibit Volume 1 - Part 2 (41 through 45)) (1)
Aug 31, 2022	226	REDACTED VERSION of 220 Letter,, by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit Volume 1 - Part 1 (A1 and 1 through 40), # 3 Exhibit Volume 1 - Part 2 (41 through 45), # 4 Exhibit Volume 1 - Part 3 (46 through 50))(Wilson, Samantha) (Entered: 08/31/2022) (Exhibit Volume 1 - Part 3 (46 through 50)) (1)
Aug 29, 2022	225	[SEALED] Letter to The Honorable Jennifer L. Hall from Jeremy A. Tigan regarding Plaintiffs' Response in Opposition to Defendants' Motion for Leave to Amend Their Answers and Counterclaims. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Tigan, Jeremy) Modified on 8/30/2022 (ceg). (Entered: 08/29/2022) (0)
Aug 26, 2022	223	STIPULATION TO EXTEND TIME for Certain Deadlines to Various Dates - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 08/26/2022) (3)
Aug 26, 2022	224	SO ORDERED re 223 STIPULATION TO EXTEND TIME for Certain Deadlines to Various Dates (Set/Reset Scheduling Order Deadlines: Opening Expert Reports due by 9/9/2022. Rebuttal Expert Reports due by 10/20/2022. Reply Expert Reports due by 11/15/2022. Expert Discovery due by 12/16/2022). SEE STIPULATION FOR FURTHER DETAILS. Signed by Judge Maryellen Noreika on 8/26/2022. (dlw) (Entered: 08/26/2022) (3)
Aug 24, 2022	220	[SEALED] Joint Letter to The Honorable Jennifer L. Hall from Anne Shea Gaza regarding in Support of Defendants' Motion for Leave to Amend Their Answers and Counterclaims - re 216 Joint MOTION for Teleconference to Resolve Defendants' Motion for Leave to Amend Their Answers and Counterclaims . (Attachments: # 1 Text of Proposed Order, # 2 Exhibit Volume 1 - Part 1 (A1 and 1 through 40), # 3 Exhibit Volume 1 - Part 2 (41 through 45), # 4 Exhibit Volume 1 - Part 3 (46 through 50))(Gaza, Anne) (Entered: 08/24/2022) (0)
Aug 24, 2022	221	[SEALED] EXHIBIT re 220 Letter,, (Volume 2 of 3 - Rest of A1 and A2 through A5) by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Gaza, Anne) (Entered: 08/24/2022) (0)
Aug 24, 2022	222	[SEALED] EXHIBIT re 220 Letter,, (Volume 3 of 3 - B through J) by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Gaza, Anne) (Entered: 08/24/2022) (0)
Aug 19, 2022	219	ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Defendants' Motion for Leave to Amend Answers and Counterclaims (D.I. 216 ). A discovery dispute teleconference is scheduled for August 31, 2022 at 2:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than August 24, 2022, the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than August 29, 2022, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 8/19/2022. (ceg) (Entered: 08/19/2022) (0)
Aug 17, 2022	218	CONSENT JUDGMENT (between Plaintiffs and DRL Defendants). Party Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. terminated. Attorney Alison M. King; Samantha G. Wilson; Jovial Wong; Bryce A. Cooper and Anne Shea Gaza terminated as to these Defendants. Signed by Judge Maryellen Noreika on 8/17/2022. (dlw) (Entered: 08/17/2022) (3)
Aug 16, 2022	216	Joint MOTION for Teleconference to Resolve Defendants' Motion for Leave to Amend Their Answers and Counterclaims - filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Gaza, Anne) (Entered: 08/16/2022) (3)
Aug 16, 2022	217	PROPOSED CONSENT JUDGMENT (between Intercept and Dr. Reddy's Laboratories) by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 8/17/2022 (dlw). (Entered: 08/16/2022) (3)
Aug 15, 2022	215	NOTICE to Take Deposition of Makarand Avachat on August 16, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 08/15/2022) (6)
Aug 11, 2022	214	ORAL ORDER - Consistent with the Scheduling Order, the parties contacted Chambers to request a teleconference date for Defendants' anticipated Motion to Amend. IT IS HEREBY ORDERED that this anticipated motion is referred to Magistrate Judge Hall. The parties are directed file Magistrate Judge Hall's "Motion for Teleconference to Resolve Discovery/Protective Order Disputes" which can be found at https://www.ded.uscourts.gov/judge/magistrate-judge-jennifer-l-hall, forms. ORDERED by Judge Maryellen Noreika on 8/11/2022. (dlw) (Entered: 08/11/2022) (0)
Aug 9, 2022	213	NOTICE OF SERVICE of 1) DRL's Supplemental Objections and Responses to Plaintiffs Second Set of Common Interrogatories to Defendants (Nos. 8-9 and 12-15); and 2) DRL's First Supplemental Objections and Responses to Plaintiffs' First Set of Common Interrogatories to Defendants (Nos. 3-5). filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Wilson, Samantha) (Entered: 08/09/2022) (2)
Aug 1, 2022	211	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Amit Mukharya on August 3, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Aug 1, 2022	212	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Kapil Gupta on August 12, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 29, 2022	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Wojciech K. Jankiewicz for Lupin Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
Jul 29, 2022	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. 206 has been replaced on the docket at the request of counsel. (dlw)
Jul 29, 2022	206	Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendants Apotex Inc. and Apotex Corp.s objections and responses to Plaintiffs First Set of Common Interrogatories (Nos. 3-6) served by Plaintiffs Intercept Pharmaceuticals, Inc. and Intercept Pharma Europe Ltd. filed by Apotex Corp., Apotex Inc..(Ormerod, Eve) (Main Document 206 replaced on 7/29/2022) (dlw).
Jul 29, 2022	207	Notice of Service (2) Docket Text: NOTICE OF SERVICE of ) Amneal's First Supplemental Objections and Responses to Plaintiffs' First Set of Common Interrogatories to Defendants (Nos. 3-6); and 2) Amneal's First Supplemental Objections and Responses to Plaintiffs' Second Set of Common Interrogatories to Defendants (Nos. 8-9, 12-15). filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC.(Wilson, Samantha)
Jul 29, 2022	208	Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) MSN's Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories to MSN (No. 1); 2) MSN's Supplemental Objections and Responses to Plaintiffs' First Set of Common Interrogatories to Defendants (Nos. 3-6); and 3) MSN's Supplemental Objections and Responses to Plaintiffs' Second Set of Common Interrogatories to Defendants (Nos. 8-9, 12-15). filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Wilson, Samantha)
Jul 29, 2022	209	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Jason Gensburger on August 3, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 29, 2022	210	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Kiran Krishnan on August 5, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 28, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [202] MOTION for Pro Hac Vice Appearance of Attorney Wojciech Jankiewicz filed by Lupin Limited, Lupin Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 7/28/2022. (dlw)
Jul 28, 2022	202	Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Wojciech Jankiewicz - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # (1) Certification of Wojciech Jankiewicz)(Haney, Megan)
Jul 28, 2022	202	Certification of Wojciech Jankiewicz (1)
Jul 28, 2022	203	Notice of Service (9) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Supplemental Responses and Objections to Defendants' Second Set of Joint Interrogatories (Nos. 8-9) and (2) Plaintiffs' Third Supplemental Responses and Objections to Defendants' First Set of Joint Interrogatories (Nos. 1-6) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 28, 2022	204	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin's Supplemental Responses and Objections to Plaintiffs' Common Interrogatories Nos. 4-5 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan)
Jul 28, 2022	205	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants, Optimus Pharma Pvt. Ltd. and Optimus Drugs Private Ltd.'s First Supplemental Objections and Responses to Plaintiffs Intercept Pharmaceuticals, Inc. and Intercept Pharma Europe Ltd.'s First Set of Common Interrogatories (Nos. 1-6) and Defendants, Optimus Pharma Pvt. Ltd. and Optimus Drugs Private Ltd.'s First Supplemental Responses and Objections to Plaintiffs' Second Set of Common Interrogatories (Nos. 7-15) filed by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd..(Myer, R.)
Jul 25, 2022	200	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Navin Vaya on July 26, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 25, 2022	201	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Martin Ehrlert on July 27, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 20, 2022	199	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Pramod Dahibhate on July 21, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 19, 2022	196	SO ORDERED (3) Docket Text: SO ORDERED re [194] Stipulation and Order Regarding Deposition of R. Pellicciari. Signed by Judge Maryellen Noreika on 7/19/2022. (dlw)
Jul 19, 2022	197	Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Martin Hoesley on July 27, 2022 filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Wilson, Samantha)
Jul 19, 2022	198	Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Dr. Roberto Pellicciari on July 21, 2022 filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Wilson, Samantha)
Jul 18, 2022	193	SO ORDERED (6) Docket Text: SO ORDERED re [192] Stipulation and Order Regarding Fact Depositions. Signed by Judge Maryellen Noreika on 7/18/2022. (dlw)
Jul 18, 2022	194	Stipulation (3) Docket Text: STIPULATION and Order Regarding Deposition of R. Pellicciari by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Wilson, Samantha)
Jul 18, 2022	195	Notice of Service (9) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Supplemental Responses and Objections to Defendants' First Set of Joint Interrogatories (No. 4) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 15, 2022	192	Stipulation (6) Docket Text: STIPULATION and Order Regarding Fact Depositions by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy)
Jul 11, 2022	190	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Final Invalidity Contentions filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Wilson, Samantha)
Jul 11, 2022	191	Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Pritesh Upadhyay on July 14, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 8, 2022	189	Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Responses and Objections to Defendants' First Set of Joint Interrogatories (Nos. 1-6) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 7, 2022	183	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Final Infringement Contentions to Amneal filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 7, 2022	184	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Final Infringement Contentions to Apotex filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 7, 2022	185	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Final Infringement Contentions to DRL filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 7, 2022	186	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Final Infringement Contentions to Lupin filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 7, 2022	187	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Final Infringement Contentions to MSN filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 7, 2022	188	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Final Infringement Contentions to Optimus filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 5, 2022	181	Notice to Take Deposition (6) Docket Text: NOTICE to Take Deposition of Kondal Reddy Bairy on July 7, 2022 filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 5, 2022	182	Notice (Other) (9) Docket Text: NOTICE of Subpoenas by Lupin Limited, Lupin Pharmaceuticals, Inc. (Haney, Megan)
Jun 28, 2022	180	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Lupin's Objections and Responses to Plaintiffs' Second Set of Common Interrogatories (Nos. 7-15) to Defendants; (2) Lupin's Objections and Responses to Plaintiffs' First Set of Common Requests for Admission (Nos. 1-20); and (3) Lupin's Objections and Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-6) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan)
Jun 27, 2022	178	Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' First Set of Requests for Admission (Nos. 1-19) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jun 27, 2022	179	Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Amneal's First Set of Individual Requests for Admission (Nos. 1-10); (2) Plaintiffs' Responses and Objections to Amneal's First Set of Individual Interrogatories (Nos. 1-3); (3) Plaintiffs' Responses and Objections to DRL's First Set of Individual Requests for Admission (Nos. 1-4); (4) Plaintiffs' Responses and Objections to DRL's First Set of Individual Interrogatories (No. 1); (5) Plaintiffs' Responses and Objections to MSN's First Set of Individual Requests for Admission (Nos. 1-10); and (6) Plaintiffs' Responses and Objections to MSN's Second Set of Individual Interrogatories (Nos. 2-4) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jun 23, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [177] MOTION for Pro Hac Vice Appearance of Attorney Eric R. Sonnenschein, Alexander R. Trzeciak, and Daniel J. Farnoly filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe LTD. ORDERED by Judge Maryellen Noreika on 6/23/2022. (dlw)
Jun 22, 2022	176	Notice of Service (1) Docket Text: NOTICE OF SERVICE of Apotex Inc. and Apotex Corp.'s 1) Responses and Objections to Plaintiffs' Second Set of Interrogatories (Nos. 7-15), 2) Responses to Plaintiffs' First Set of Common Requests for Admission (Nos. 1-20), and 3) Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-5) filed by Apotex Corp., Apotex Inc..(Ormerod, Eve)
Jun 22, 2022	177	Motion for Leave to Appear Pro Hac Vice (9) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Eric R. Sonnenschein, Alexander R. Trzeciak, and Daniel J. Farnoly - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy)
Jun 21, 2022	173	Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Amneal's Objections and Responses to Plaintiffs' Second Set of Common Interrogatories to Defendants (Nos. 7-15); 2) Defendants Amneal EU, Limited and Amneal Pharmaceuticals of New York, LLC's Responses and Objections to Plaintiffs' First Set of Common Requests for Admission (Nos. 1- 20); and 3) Defendants Amneal EU, Limited and Amneal Pharmaceuticals of New York, LLC's Responses and Objections to Plaintiffs' First Set of Requests for Admission to Amneal (Nos. 1- 8) filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC.(Wilson, Samantha)
Jun 21, 2022	174	Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) DRL's Objections and Responses to Plaintiffs' Second Set of Common Interrogatories to Defendants (Nos. 7-15); 2) Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s Responses and Objections to Plaintiffs' First Set of Requests for Admission to DRL (Nos. 1-8); 3) Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s Responses and Objections to Plaintiffs' First Set of Common Requests for Admission (Nos. 1- 20) filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Wilson, Samantha)
Jun 21, 2022	175	Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.'s Responses and Objections to Plaintiffs' First Set of Common Requests for Admission (Nos. 1- 20); 2) Defendants MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.'s Responses and Objections to Plaintiffs' First Set of Requests for Admission to MSN (Nos. 1-5); and 3) MSN's Objections and Responses to Plaintiffs' Second Set of Common Interrogatories to Defendants (Nos. 7-15) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Wilson, Samantha)
Jun 20, 2022	172	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants, Optimus Pharma Pvt. Ltd. and Optimus Drugs Private Ltd.'s Responses and Objections to Plaintiffs' First Set of Common Requests for Admission (Nos. 1-20); Defendants, Optimus Pharma Pvt. Ltd. and Optimus Drugs Private Ltd.'s Responses and Objections to Plaintiffs' First Set of Requests for Admission to Optimus (Nos. 1-6); and Defendants, Optimus Pharma Pvt. Ltd. and Optimus Drugs Private Ltd.'s Responses and Objections to Plaintiffs' Second Set of Common Interrogatories (Nos. 7-15) filed by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd..(Myer, R.)
Jun 13, 2022	170	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin's Objections and Responses to Plaintiffs' Notice of Deposition to Defendant Lupin Under Fed. R. Civ. P. 30(b)(6) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan)
Jun 13, 2022	171	Notice of Service (7) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Defendants' Second Set of Joint Interrogatories (Nos. 7-9) and (2) Plaintiffs' Responses and Objections to Defendants' Fourth Set of Requests for the Production of Documents and Things (Nos. 69-74) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jun 10, 2022	168	SO ORDERED (4) Docket Text: SO ORDERED WITH MODIFICATIONS re [167] STIPULATION TO EXTEND TIME regarding Scheduling Order Deadlines (Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 7/28/2022. Opening Expert Reports due by 8/29/2022. Rebuttal Expert Reports due by 10/10/2022. Reply Expert Reports due by 11/7/2022. Expert Discovery due by 12/7/2022). *See Stipulation regarding Daubert motions provisions* Signed by Judge Maryellen Noreika on 6/10/2022. (dlw)
Jun 10, 2022	169	Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Amended Initial Disclosures Pursuant to Rule 26(a)(1) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jun 9, 2022	164	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Amneal's Responses and Objections to Plaintiffs' Notice of Deposition Under Fed. R. of Civ. P. 30(b)(6) filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC.(Wilson, Samantha)
Jun 9, 2022	165	Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN's Responses and Objections to Plaintiffs' Notice of Deposition Under Fed. R. of Civ. P. 30(b)(6) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Wilson, Samantha)
Jun 9, 2022	166	Notice of Service (2) Docket Text: NOTICE OF SERVICE of DRL's Responses and Objections to Plaintiffs' Notice of Deposition Under Fed. R. of Civ. P. 30(b)(6) filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Wilson, Samantha)
Jun 9, 2022	167	Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME regarding Scheduling Order Deadlines - See Stipulation to - filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Wilson, Samantha)
Jun 8, 2022	162	Notice of Service (1) Docket Text: NOTICE OF SERVICE of Apotex's Responses and Objections to Notice of Deposition of Defendant Apotex Under Fed R. Civ. P. (30)(b)(6) filed by Apotex Corp., Apotex Inc..(Ormerod, Eve)
Jun 8, 2022	163	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants, Optimus Pharma Pvt. Ltd. and Optimus Drugs Private Ltd.'s Objections to Plaintiffs' Notice of Deposition to Defendant Optimus Under Fed. R. Civ. P. 30(b)(6) filed by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd..(Myer, R.)
Jun 3, 2022	156	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Jason Campagna on June 28, 2022 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan)
Jun 3, 2022	157	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Victoria Carey on June 27, 2022 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan)
Jun 3, 2022	158	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Lise Eliot on June 24, 2022 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan)
Jun 3, 2022	159	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Richard Lancaster on June 29, 2022 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan)
Jun 3, 2022	160	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Peter Malanga on June 23, 2022 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan)
Jun 3, 2022	161	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Christian Weyer on June 22, 2022 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan)
Jun 2, 2022	155	Notice of Service (9) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Notice of Deposition pursuant to Fed. R. Civ. P. 30(b)(6) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
May 31, 2022	151	Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Amneal's First Set of Individual Requests for Admission (Nos. 1-10); and 2) Amneal's First Set of Individual Interrogatories (Nos. 1-3) filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC.(Wilson, Samantha)
May 31, 2022	152	Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) DRL's First Set of Individual Requests for Admission (Nos. 1-4); and 2) DRL's First Set of Individual Interrogatories (No. 1) filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Wilson, Samantha)
May 31, 2022	153	Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) MSN's First Set of Individual Requests for Admission (Nos. 1-10); and 2) MSN's Second Set of Individual Interrogatories (Nos. 2-4) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Wilson, Samantha)
May 31, 2022	154	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Requests for Admission (Nos. 1 19) filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Wilson, Samantha)
May 20, 2022	150	Notice of Service (7) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Set of Common Requests for Admission (Nos. 1-20); (2) Plaintiffs' Second Set of Common Interrogatories (Nos. 7-15) to Defendants; (3) Plaintiffs' First Set of Requests for Admission to Amneal (Nos. 1-8); (4) Plaintiffs' First Set of Requests for Admission to Apotex (Nos. 1-5); (5) Plaintiffs' First Set of Requests for Admission to DRL (Nos. 1-8); (6) Plaintiffs' First Set of Requests for Admission to Lupin (Nos. 1-6); (7) Plaintiffs' First Set of Requests for Admission to MSN (Nos. 1-5); and (8) Plaintiffs' First Set of Requests for Admission to Optimus (Nos. 1-6) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
May 9, 2022	149	Notice of Service (10) Docket Text: NOTICE OF SERVICE of Plaintiffs' Notices of Deposition to Defendants Under Fed. R. Civ. P. 30(b)(6) (directed to various defendants as outlined in notice) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
May 6, 2022	147	Notice to Take Deposition (10) Docket Text: NOTICE to Take Deposition of Intercept Pharmaceuticals, Inc. and Intercept Pharma Europe Ltd. filed by Apotex Corp., Apotex Inc..(Ormerod, Eve)
May 6, 2022	148	Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Guylaine Hache as co-counsel. Reason for request: No Longer with Firm. (Haney, Megan)
Apr 25, 2022	145	Stipulation (2) Docket Text: STIPULATION Regarding Claim Construction by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy)
Apr 25, 2022	146	SO ORDERED (2) Docket Text: SO ORDERED re [145] Stipulation Regarding Claim Construction. Signed by Judge Maryellen Noreika on 4/25/2022. (dlw)
Apr 4, 2022	N/A	Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. § 652(b). (Taylor, Daniel)
Mar 30, 2022	144	SO ORDERED (2) Docket Text: SO ORDERED re [143] Stipulation and Order to Modify Protective Order. Signed by Judge Maryellen Noreika on 3/30/2022. (dlw)
Mar 29, 2022	143	Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to Modify Protective Order re [56] Protective Order by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy)
Mar 23, 2022	142	Memorandum and Order (10) Docket Text: MEMORANDUM ORDER REGARDING CLAIM CONSTRUCTION. Signed by Judge Maryellen Noreika on 3/23/2022. (dlw)
Mar 21, 2022	141	Transcript (70) Docket Text: Official Transcript of Markman Hearing held on 03/04/2022 before Judge Maryellen Noreika. Court Reporter/Transcriber Dale C. Hawkins,Email: Dale_Hawkins@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/11/2022. Redacted Transcript Deadline set for 4/21/2022. Release of Transcript Restriction set for 6/21/2022. (dh)
Mar 17, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [140] MOTION for Pro Hac Vice Appearance of Attorney Laura M. Martin filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe LTD. ORDERED by Judge Maryellen Noreika on 3/17/2022. (dlw)
Mar 17, 2022	140	Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Laura M. Martin - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy)
Mar 11, 2022	139	Notice Requesting Removal of Co-Counsel (5) Docket Text: NOTICE requesting Clerk to remove Laura Dolbow as co-counsel. Reason for request: No longer with firm. (Tigan, Jeremy)
Mar 4, 2022	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. [138] replaced per counsels request. (apk)
Mar 4, 2022	N/A	Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Maryellen Noreika - Markman Hearing held on 3/4/2022. (Court Reporter Dale Hawkins.) (mdb)
Mar 3, 2022	138	Notice (Other) (2) Docket Text: NOTICE of Change of Firm Name and E-Mail Addresses for Apotex's Pro Hac Vice Counsel by Apotex Corp., Apotex Inc. (Ormerod, Eve) (Main Document 138 replaced on 3/4/2022) (apk).
Feb 28, 2022	137	Claim Construction Chart (10) Docket Text: FIRST AMENDED JOINT CLAIM Construction Chart by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 3/1/2022 (dlw).
Feb 25, 2022	136	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Amneal's Objections and Responses to Plaintiffs' Second Set of Requests for Production of Documents and Things to Amneal (Nos. 84-87) filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC.(Wilson, Samantha)
Feb 24, 2022	N/A	Oral Order (0) Docket Text: ORAL ORDER re [133] Letter - IT IS HEREBY ORDERED that the request to hold the 3/4/2022 Markman hearing remotely is DENIED. ORDERED by Judge Maryellen Noreika on 2/24/2022. (dlw)
Feb 24, 2022	135	Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Third Set of Requests for the Production of Documents and Things (No. 68) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Feb 23, 2022	132	Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Second Set of Requests for the Production of Documents and Things (Nos. 56-67) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Feb 23, 2022	133	Letter (2) Docket Text: Letter to The Honorable Maryellen Noreika from Eve H. Ormerod, Esq. regarding Markman hearing. (Ormerod, Eve)
Feb 18, 2022	131	Letter (1) Docket Text: Joint Letter to The Honorable Maryellen Noreika from Jeremy A. Tigan regarding Claim Construction. (Tigan, Jeremy)
Feb 17, 2022	127	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin's Responses and Objections to Plaintiffs' Second Set of Requests for Production (Nos. 84-86) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan)
Feb 17, 2022	128	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants, Optimus Pharma Pvt. Ltd. and Optimus Drugs Private Ltd.'s Responses and Objections to Plaintiffs' First Set of Interrogatories (No. 1) and Defendants, Optimus Pharma Pvt. Ltd. and Optimus Drugs Private Ltd.'s Responses and Objections to Plaintiffs' Second Set of Requests for Production of Documents and Things to Optimus (Nos. 84-86) filed by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd..(Myer, R.)
Feb 17, 2022	129	Notice of Service (2) Docket Text: NOTICE OF SERVICE of DRL's Objections and Responses to Plaintiffs' Second Set of Requests for Production of Documents and Things to DRL (Nos. 85-87) filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Wilson, Samantha)
Feb 17, 2022	130	Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN's Objections and Responses to Plaintiffs' Second Set of Requests for Production of Documents and Things to MSN (Nos. 85-89) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Wilson, Samantha)
Feb 11, 2022	126	SO ORDERED (3) Docket Text: SO ORDERED re [125] STIPULATION TO EXTEND Various Scheduling Order Deadlines (Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 6/30/2022. Opening Expert Reports due by 8/9/2022. Rebuttal Expert Reports due by 9/19/2022. Reply Expert Reports due by 10/19/2022. Expert Discovery due by 11/18/2022. Daubert Motions due by 11/29/2022. Answering Brief due 12/15/2022. Reply Brief due 12/23/2022). Signed by Judge Maryellen Noreika on 2/11/2022. (dlw)
Feb 10, 2022	125	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for Scheduling Order Deadlines to Various Dates - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy)
Feb 8, 2022	124	Notice of Service (1) Docket Text: NOTICE OF SERVICE of Apotex Inc. and Apotex Corp.'s Objections and Responses to Plaintiffs' Second Set of Requests for Production (Nos. 84-87) filed by Apotex Corp., Apotex Inc..(Ormerod, Eve)
Feb 4, 2022	N/A	Multi Media Document (0) Docket Text: MULTI MEDIA DOCUMENT filed by Intercept Pharma Europe LTD. in the form of a CD Rom. Filing related to [120] Notice of Lodging Plaintiffs' Technology Tutorial. (Media on file in Clerk's Office). (mdb)
Feb 4, 2022	N/A	Oral Order (0) Docket Text: ORAL ORDER re [115] Joint Claim Construction Brief - IT IS HEREBY ORDERED that on or before 2/18/2022, local and lead counsel (i.e., those attorneys that will be leading trial) for the parties shall meet and confer and file an amended joint claim construction chart that sets forth the terms that remain in dispute. The meet and confer shall focus on an attempt to reach agreement on any remaining disputed terms where possible and on an attempt to focus the dispute over the remaining terms in light of the joint claim construction brief. Accompanying any amended joint claim construction chart, the parties shall file a letter with the Court identifying by name each individual who participated in the meet and confer, when and how that meet and confer occurred and how long it lasted. If no agreements on constructions have been reached or if no dispute has been narrowed on the meet and confer, the letter shall so state and the parties need not file an amended joint claim construction chart. ORDERED by Judge Maryellen Noreika on 2/4/2022. (dlw)
Feb 4, 2022	N/A	Oral Order (0) Docket Text: ORAL ORDER re [119] Letter - IT IS HEREBY ORDERED that the Court is setting aside 1.5 hours for the 3/4/2022 claim construction hearing with the time split equally between the sides. Any slide presentations the parties wish to use during the hearing shall be emailed (in PDF format) to MN_civil@ded.uscourts.gov no later than 24 hours prior to the hearing. The parties may, however, agree upon a different time to exchange their respective slides. Counsel shall also provide to the Court two courtesy copies of the slide presentations. ORDERED by Judge Maryellen Noreika on 2/4/2022. (dlw)
Feb 3, 2022	115	Joint Claim Construction Brief (30) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe LTD.. (Tigan, Jeremy)
Feb 3, 2022	116	Appendix (30) Docket Text: Joint APPENDIX - Volume 1 (Exhibits A-J) re [115] Joint Claim Construction Brief by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 2/4/2022 (dlw).
Feb 3, 2022	117	Appendix (30) Docket Text: Joint APPENDIX Volume 2 of 3 (Exhibits K-K.16) re [115] Joint Claim Construction Brief by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 2/4/2022 (dlw).
Feb 3, 2022	118	Appendix (30) Docket Text: Joint APPENDIX Volume 3 of 3 (Exhibits L-R) re [115] Joint Claim Construction Brief by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 2/4/2022 (dlw).
Feb 3, 2022	119	Letter (1) Docket Text: Joint Letter to The Honorable Maryellen Noreika from Jeremy A. Tigan regarding Markman Hearing. (Tigan, Jeremy)
Feb 3, 2022	120	Notice (Other) (5) Docket Text: NOTICE of Lodging (technology tutorial) by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 2/4/2022 (dlw).
Feb 2, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [114] STIPULATION TO EXTEND TIME for the parties to (1) submit a Joint Claim Construction Brief and Joint Appendix; (2) submit any technology tutorials; and (3) notify the Court about their requests for the length and format of the Markman hearing to February 3, 2022. ORDERED by Judge Maryellen Noreika on 2/2/2022. (dlw)
Feb 2, 2022	114	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to (1) submit a Joint Claim Construction Brief and Joint Appendix; (2) submit any technology tutorials; and (3) notify the Court about their requests for the length and format of the Markman hearing to February 3, 2022 - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy)
Jan 28, 2022	113	Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by Apotex Corp., Apotex Inc..(Ormerod, Eve)
Jan 26, 2022	112	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for Production of Documents and Things to Amneal (Nos. 84-87) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jan 25, 2022	110	Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendants' Second Set of Requests for Production (Nos. 56-67) filed by Apotex Corp., Apotex Inc..(Ormerod, Eve)
Jan 25, 2022	111	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Third Set of Joint Requests for Production to Plaintiffs (No. 68) filed by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd..(Myer, R.)
Jan 18, 2022	105	Notice of Service (6) Docket Text: NOTICE OF SERVICE of Plaintiffs' [Confidential] Second Set of Requests for Production of Documents and Things to Apotex (Nos. 84-87) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jan 18, 2022	106	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for Production of Documents and Things to DRL (Nos. 85-87) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jan 18, 2022	107	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for Production of Documents and Things to Lupin (Nos. 84-86) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jan 18, 2022	108	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for Production of Documents and Things to MSN (Nos. 85-89) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jan 18, 2022	109	Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Second Set of Requests for Production of Documents and Things to Optimus (Nos. 84-86) and (2) Plaintiffs' First Set of Interrogatories (No. 1) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jan 7, 2022	104	Notice of Service (9) Docket Text: NOTICE OF SERVICE of Intercept's Reply Markman Brief filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Dec 20, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael P. Hogan for Optimus Drugs Private Ltd. and Optimus Pharma Pvt. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
Dec 2, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [103] MOTION for Pro Hac Vice Appearance of Attorney Matthew M. Holub filed by Lupin Limited, Lupin Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 12/2/2021. (dlw)
Dec 2, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Matthew M. Holub for Lupin Limited and Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
Dec 2, 2021	103	Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Matthew M. Holub - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # (1) Certification of Mathew M. Holub)(Haney, Megan)
Dec 2, 2021	103	Certification of Mathew M. Holub (1)
Dec 1, 2021	102	Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendants' Answering Claim Construction Brief filed by Apotex Corp., Apotex Inc..(Ormerod, Eve)
Nov 10, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Matthew T. Wilkerson for Apotex Corp.,Matthew T. Wilkerson for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk)
Nov 9, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [100] MOTION for Pro Hac Vice Appearance of Attorney Matthew T. Wilkerson filed by Apotex Inc., Apotex Corp. ORDERED by Judge Maryellen Noreika on 11/9/2021. (dlw)
Nov 9, 2021	100	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Matthew T. Wilkerson - filed by Apotex Corp., Apotex Inc.. (Ormerod, Eve)
Nov 9, 2021	101	Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by R. Touhey Myer (Myer, R.)
Oct 27, 2021	99	Notice of Service (9) Docket Text: NOTICE OF SERVICE of (1) Intercept's Opening Markman Brief and (2) Declaration of Allan S. Myerson, Ph.D. filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Oct 15, 2021	98	Notice Requesting Removal of Co-Counsel (5) Docket Text: NOTICE requesting Clerk to remove Jeremy Cobb as co-counsel. Reason for request: No Longer with Firm. (Tigan, Jeremy)
Oct 12, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Helen H. Ji for Apotex Corp. and Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
Oct 8, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [96] MOTION for Pro Hac Vice Appearance of Attorney Helen H. Ji filed by Apotex Inc., Apotex Corp. ORDERED by Judge Maryellen Noreika on 10/8/2021. (dlw)
Oct 8, 2021	96	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Helen H. Ji - filed by Apotex Corp., Apotex Inc.. (Ormerod, Eve)
Oct 8, 2021	97	Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Appearance of Arun J. Mohan by Apotex Corp., Apotex Inc. (Ormerod, Eve)
Oct 1, 2021	95	Claim Construction Chart (12) Docket Text: JOINT CLAIM Construction Chart by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 10/4/2021 (dlw).
Sep 29, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [94] STIPULATION TO EXTEND TIME to file a Joint Claim Construction Chart to October 1, 2021. ORDERED by Judge Maryellen Noreika on 9/29/2021. (dlw)
Sep 29, 2021	94	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file a Joint Claim Construction Chart to October 1, 2021 - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy)
Sep 24, 2021	93	Notice (Other) (6) Docket Text: NOTICE of Withdrawal of Counsel (Andrew M. Moshos) by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Moshos, Andrew)
Sep 16, 2021	92	Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendants' Rebuttal Evidence to Plaintiff's Proposed Claim Constructions and Intrinsic Evidentiary Support filed by Apotex Corp., Apotex Inc..(Ormerod, Eve)
Sep 15, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [90] MOTION for Pro Hac Vice Appearance of Attorney George C. Lombardi and Maureen L. Rurka filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd. ORDERED by Judge Maryellen Noreika on 9/15/2021. (dlw)
Sep 15, 2021	90	Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George C. Lombardi and Maureen L. Rurka - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Wilson, Samantha)
Sep 15, 2021	91	Notice of Service (9) Docket Text: NOTICE OF SERVICE of Plaintiffs' Identification of Intrinsic Evidentiary Support in Opposition to Defendants' Proposed Constructions filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Sep 10, 2021	87	Notice Requesting Removal of Co-Counsel (4) Docket Text: NOTICE requesting Clerk to remove Kevin Warner as co-counsel.. (Wilson, Samantha)
Sep 10, 2021	88	Notice Requesting Removal of Co-Counsel (4) Docket Text: NOTICE requesting Clerk to remove Kevin Warner as co-counsel.. (Wilson, Samantha)
Sep 10, 2021	89	Notice Requesting Removal of Co-Counsel (4) Docket Text: NOTICE requesting Clerk to remove Kevin Warner as co-counsel.. (Wilson, Samantha)
Sep 1, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [86] MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan filed by Optimus Pharma Pvt. Ltd., Optimus Drugs Private Ltd. ORDERED by Judge Maryellen Noreika on 9/1/2021. (dlw)
Aug 31, 2021	86	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan - filed by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd.. (Myer, R.)
Aug 30, 2021	85	Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendants Proposed Claim Constructions and Intrinsic Support filed by Apotex Corp., Apotex Inc..(Ormerod, Eve)
Aug 27, 2021	84	Notice of Service (9) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Constructions and Identification of Intrinsic Evidentiary Support filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Aug 26, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [83] Joint STIPULATION TO EXTEND TIME for the parties to exchange proposed constructions and intrinsic evidentiary support to August 27, 2021. ORDERED by Judge Maryellen Noreika on 8/26/2021. (dlw)
Aug 25, 2021	83	Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME for the parties to exchange proposed constructions and intrinsic evidentiary support to August 27, 2021 - filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Wilson, Samantha)
Aug 18, 2021	80	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Amneal's First Amended Objections and Responses to Plaintiffs' First Set of Requests for Production of Documents and Things to Amneal (Nos. 1-83) filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC.(Wilson, Samantha)
Aug 18, 2021	81	Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) MSN's First Amended Objections and Responses to Plaintiffs' First Set of Requests for Production of Documents and Things to MSN (Nos. 1-84); and 2) MSN's Supplemental Objections and Responses to Plaintiffs' Common Interrogatory No. 6 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Wilson, Samantha)
Aug 18, 2021	82	Notice of Service (3) Docket Text: NOTICE OF SERVICE of DRL's First Amended Objections and Responses to Plaintiffs' First Set of Requests for Production of Documents and Things to DRL (Nos. 1-84) filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Wilson, Samantha)
Aug 2, 2021	79	Notice of Service (9) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Defendants' First Set of Requests for the Production of Documents and Things (Nos. 1-55), and (2) Plaintiffs' Responses and Objections to Defendants' First Set of Joint Interrogatories (Nos. 1-6) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 28, 2021	77	Notice of Service (9) Docket Text: NOTICE OF SERVICE of Plaintiffs' Proposed Terms for Construction filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 28, 2021	78	Notice of Service (1) Docket Text: NOTICE OF SERVICE of Defendants' Proposed Terms for Construction filed by Apotex Corp., Apotex Inc..(Ormerod, Eve)
Jul 12, 2021	76	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to MSN's First Set of Interrogatories (No. 1) filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 8, 2021	75	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Apotex Corp., Apotex Inc..(Ormerod, Eve)
Jul 6, 2021	74	Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Defendants' First Set of Requests for the Production of Documents and Things to Plaintiffs Intercept Pharmaceuticals, Inc. and Intercept Pharma Europe Ltd. (Nos. 1-55); and 2) Defendants' First Set of Joint Interrogatories (Nos. 1-6) filed by Apotex Corp., Apotex Inc..(Ormerod, Eve)
Jun 29, 2021	73	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Optimus Defendants' Responses and Objections to Plaintiffs Intercept Pharmaceuticals, Inc and Intercept Pharma Europe Ltd 1st set of Common Interrogatories Nos 1 - 6 and Optimus Defendants' Responses and Objections to Plaintiffs Intercept Pharmaceuticals, Inc., and Intercept Pharma Europe Ltd, 1st set of Requests for Production of Docs and Things - Nos. 1 - 83 filed by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd..(Myer, R.)
Jun 28, 2021	68	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin's [CONFIDENTIAL] Responses and Objections to Plaintiffs' FIrst Set of Requests for Production (Nos. 1-83) and Lupin's [CONFIDENTIAL] Responses and Objections to Plaintiffs' First Set of Common Interrogatories (Nos. 1-6) filed by Lupin Limited.(Haney, Megan)
Jun 28, 2021	69	Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Objections and Responses to Plaintiffs' First Set of Common Interrogatories (Nos. 1-6) to Defendants) and 2) Objections and Responses to Plaintiffs' First Set of Requestse for Production of DOcuments and Things to Apotex (Nos. 1-83) filed by Apotex Corp., Apotex Inc..(Ormerod, Eve)
Jun 28, 2021	70	Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) DRL's Objections and Responses to Plaintiffs' First Set of Requests For Production Of Documents and Things To DRL (Nos. 1-84), 2) DRL's Objections and Responses to Plaintiffs' First Set of Common Interrogatories to Defendants (Nos. 1-6), and 3) DRL's Objections and Responses to Plaintiffs' First Set of Interrogatories to DRL (No. 1) filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Wilson, Samantha)
Jun 28, 2021	71	Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Amneal's Objections and Responses to Plaintiffs' First Set of Requests for Production of Documents and Things to Amneal (Nos. 1-83), and 2) Amneal's Objections and Responses to Plaintiffs' First Set of Common Interrogatories to Defendants (Nos. 1-6) filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC.(Wilson, Samantha)
Jun 28, 2021	72	Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) MSN's Objections and Responses to Plaintiffs' First Set of Requests For Production of Documents and Things to MSN (Nos. 1-84), 2) MSN's Objections and Responses to Plaintiffs' First Set of Interrogatories to MSN (No. 1), and 3) MSN's Objections and Responses to Plaintiffs' First Set of Common Interrogatories to Defendants (Nos. 1-6) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Wilson, Samantha)
Jun 24, 2021	67	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Production of Documents Bearing Bates Nos. OPTIMUS_0052453 - OPTIMUS_0056156 filed by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd..(Myer, R.)
Jun 11, 2021	66	Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN's First Set of Interrogatories to Plaintiffs (No. 1) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Wilson, Samantha)
Jun 3, 2021	65	Notice of Service (10) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories (No. 1) to MSN, (2) Plaintiffs' First Set of Interrogatories (No. 1) to DRL, (3) Plaintiffs' First Set of Requests for Production of Documents and Things (directed to various defendants as outlined in notice) and (4) Plaintiffs' First Set of Common Interrogatories (Nos. 1-6) to Defendants filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Jun 1, 2021	64	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Production of Documents Bearing Bates Nos. OPTIMUS_0048243 OPTIMUS_0052452 filed by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd..(Myer, R.)
May 19, 2021	58	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions to Amneal filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
May 19, 2021	59	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions to Apotex filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
May 19, 2021	60	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions to DRL filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
May 19, 2021	61	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions to Lupin filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
May 19, 2021	62	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions to MSN filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
May 19, 2021	63	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions to Optimus filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Apr 30, 2021	57	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Production of Documents Bearing Bates Nos. OPTIMUS_0024219 OPTIMUS_0048242 filed by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd..(Myer, R.)
Apr 26, 2021	55	Proposed Order (24) Docket Text: PROPOSED ORDER // Protective Order re [53] Transcript by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 4/26/2021 (dlw).
Apr 26, 2021	56	Protective Order (24) Docket Text: STIPULATED PROTECTIVE ORDER. Signed by Judge Maryellen Noreika on 4/26/2021. (dlw)
Apr 20, 2021	54	Notice (Other) (4) Docket Text: NOTICE of Name Change for Certain Pro Hac Vice Counsel by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC, Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd., MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. (Wilson, Samantha)
Apr 19, 2021	53	Transcript (30) Docket Text: Official Transcript of Teleconference held on 04/13/2021 before Judge Maryellen Noreika. Court Reporter/Transcriber Dale C. Hawkins,Email: Dale_Hawkins@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/10/2021. Redacted Transcript Deadline set for 5/20/2021. Release of Transcript Restriction set for 7/19/2021. (dh)
Apr 13, 2021	N/A	Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Maryellen Noreika - Telephone Conference re Protective Order dispute - Letters ([49], [50], [51], [52]) held on 4/13/2021. The transcript shall serve as the court's ruling. (Court Reporter: Dale Hawkins.) (asw)
Apr 8, 2021	51	Main Document (4) Docket Text: Letter to The Honorable Maryellen Noreika from Eve H. Ormerod regarding Discovery Dispute Response - re [50] Letter. (Attachments: # (1) Exhibits 1-3)(Ormerod, Eve)
Apr 8, 2021	51	Exhibits 1-3 (84)
Apr 8, 2021	52	Main Document (4) Docket Text: Letter to The Honorable Maryellen Noreika from Jeremy A. Tigan regarding Response to Defendants' Letter Regarding Protective Order Disputes - re [49] Letter. (Attachments: # (1) Exhibit A-B)(Tigan, Jeremy)
Apr 8, 2021	52	Exhibit A-B (10)
Apr 7, 2021	49	Letter (4) Docket Text: Letter to The Honorable Maryellen Noreika from Eve H. Ormerod regarding the parties disputes over the proposed protective order - re [37] Order Setting Teleconference,,. (Ormerod, Eve)
Apr 7, 2021	50	Main Document (5) Docket Text: Letter to The Honorable Maryellen Noreika from Jeremy A. Tigan regarding Protective Order Disputes. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Tigan, Jeremy)
Apr 7, 2021	50	Exhibit A (26)
Apr 7, 2021	50	Exhibit B (2)
Apr 1, 2021	46	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Amneal EU, Limited and Amneal Pharmaceuticals of New York, LLC's Core Technical Documents filed by Amneal EU, Limited, Amneal Pharmaceuticals of New York, LLC.(Wilson, Samantha)
Apr 1, 2021	47	Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.'s Core Technical Documents filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Wilson, Samantha)
Apr 1, 2021	48	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s Core Technical Documents filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Wilson, Samantha)
Mar 31, 2021	42	Notice of Service (1) Docket Text: NOTICE OF SERVICE of Core Technical Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by Apotex Corp., Apotex Inc..(Ormerod, Eve)
Mar 31, 2021	43	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Core Technical Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by Optimus Drugs Private Ltd., Optimus Pharma Pvt. Ltd..(Myer, R.)
Mar 31, 2021	44	Answer to Counterclaim (29) Docket Text: ANSWER to [41] Answer to Amended Complaint, Counterclaim by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Mar 31, 2021	45	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin's Core Technical Documents filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan)
Mar 17, 2021	41	Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [35] Amended Complaint, Separate Defenses, and, COUNTERCLAIM against Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. by Apotex Inc., Apotex Corp.(Ormerod, Eve) Modified on 3/18/2021 (dlw).
Mar 15, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [40] MOTION for Pro Hac Vice Appearance of Attorney Claire A. Fundakowski filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd. ORDERED by Judge Maryellen Noreika on 3/15/2021. (dlw)
Mar 12, 2021	39	SO ORDERED (5) Docket Text: SO ORDERED re (40 in 1:20-cv-01214-MN, 32 in 1:20-cv-01155-MN, 36 in 1:20-cv-01215-MN, 34 in 1:20-cv-01154-MN, 21 in 1:21-cv-00035-MN, 38 in 1:20-cv-01105-MN) Stipulation and Order to Consolidate. ALL FUTURE FILINGS SHALL BE MADE IN C.A. NO. 20-1105. Signed by Judge Maryellen Noreika on 3/12/2021. (dlw)
Mar 12, 2021	40	Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Claire A. Fundakowski - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Wilson, Samantha)
Mar 10, 2021	38	Stipulation (5) Docket Text: STIPULATION and Order to Consolidate by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd.. (Tigan, Jeremy)
Mar 9, 2021	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: Having been advised by the parties of their inability to resolve protective order disputes, IT IS HEREBY ORDERED that a Telephone Conference is set for 4/13/2021 at 12:00 PM before Judge Maryellen Noreika. The opening letter, not to exceed three (3) pages, is due on or before 4/7/2021 and shall attach a copy of the proposed protective order setting forth Plaintiffs' and Defendants' positions. The responsive letter, not to exceed three (3) pages, is due on or before 4/8/2021. Counsel shall provide a dial-in number for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 3/9/2021. (dlw)
Mar 4, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [33] UNOPPOSED MOTION for Leave to File Second Amended Complaint. ORDERED by Judge Maryellen Noreika on 3/4/2021. (dlw)
Mar 4, 2021	35	Main Document (29) Docket Text: SECOND AMENDED COMPLAINT against Apotex Corp., Apotex Inc.- filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe LTD. (Attachments: # (1) Exhibit A - G, # (2) Redline Comparison)(dlw)
Mar 4, 2021	35	Exhibit A - G (524)
Mar 4, 2021	35	Redline Comparison (34)
Mar 4, 2021	36	Patent/Trademark Report to Commissioner (1) Docket Text: AMENDED Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE48,286; 10,758,549; 9,238,673; 10,047,117; 10,052,337; 10,174,073. (Blumenfeld, Jack) Modified on 3/4/2021 (dlw).
Mar 4, 2021	35	Amended Complaint* (1)
Mar 3, 2021	33	Main Document (3) Docket Text: UNOPPOSED MOTION for Leave to File Second Amended Complaint - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Attachments: # (1) Exhibit 1 -Second Amended Complaint, # (2) Exhibits A-G to Second Amended Complaint, # (3) Exhibits 2-3)(Blumenfeld, Jack) Modified on 3/4/2021 (dlw).
Mar 3, 2021	33	Exhibit 1 -Second Amended Complaint (29)
Mar 3, 2021	33	Exhibits A-G to Second Amended Complaint (524)
Mar 3, 2021	33	Exhibits 2-3 (37)
Mar 3, 2021	34	Notice of Service (10) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patents filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc..(Tigan, Jeremy)
Feb 26, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED re (37 in 1:20-cv-01214-MN, 31 in 1:20-cv-01154-MN, 17 in 1:21-cv-00035-MN, 32 in 1:20-cv-01105-MN, 33 in 1:20-cv-01215-MN, 29 in 1:20-cv-01155-MN) STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to March 5, 2021. ORDERED by Judge Maryellen Noreika on 2/26/2021. (dlw)
Feb 26, 2021	32	Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to March 5, 2021 - filed by Apotex Corp., Apotex Inc.. (Ormerod, Eve)
Feb 22, 2021	N/A	Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Should any party (or all parties) desire to discuss mediation and its timing, the party(ies) shall contact Judge Thynges Judicial Administrator to request that a teleconference be scheduled. Ordered by Judge Mary Pat Thynge on 2/22/21. Associated Cases: 1:20-cv-01105-MN, 1:20-cv-01154-MN, 1:20-cv-01155-MN, 1:20-cv-01214-MN, 1:20-cv-01215-MN(cak)
Feb 19, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED re (35 in 1:20-cv-01214-MN, 27 in 1:20-cv-01155-MN, 30 in 1:20-cv-01105-MN, 31 in 1:20-cv-01215-MN, 29 in 1:20-cv-01154-MN, 15 in 1:21-cv-00035-MN) STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to February 26, 2021. ORDERED by Judge Maryellen Noreika on 2/19/2021. (dlw)
Feb 19, 2021	30	Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to February 26, 2021 - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy)
Feb 12, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED re (29 in 1:20-cv-01105-MN, 26 in 1:20-cv-01155-MN, 30 in 1:20-cv-01215-MN, 34 in 1:20-cv-01214-MN, 28 in 1:20-cv-01154-MN) STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to February 19, 2021. ORDERED by Judge Maryellen Noreika on 2/12/2021. (dlw)
Feb 12, 2021	29	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to February 19, 2021 - filed by Apotex Corp., Apotex Inc.. (Ormerod, Eve)
Feb 3, 2021	27	Notice of Service (1) Docket Text: NOTICE OF SERVICE of 1) Defendants Apotex Inc. and Apotex Corp.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and 2) Defendants Apotex Inc. and Apotex Corp.'s Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Apotex Corp., Apotex Inc..(Ormerod, Eve)
Feb 3, 2021	28	Notice of Service (10) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Rule 26(A)(1); and (2) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc..(Blumenfeld, Jack)
Jan 27, 2021	N/A	Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:20-cv-01105-MN, 1:20-cv-01154-MN, 1:20-cv-01155-MN, 1:20-cv-01214-MN, 1:20-cv-01215-MN(cak)
Jan 27, 2021	26	Scheduling Order (15) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 9/10/2021. Amended Pleadings due by 9/10/2021. Fact Discovery completed by 5/30/2022. Opening Expert Reports due by 7/11/2022. Rebuttal Expert Reports due by 8/22/2022. Reply Expert Reports due by 9/26/2022. Daubert Motions due by 11/21/2022. Answering Brief due 12/12/2022. Reply Brief due 12/20/2022. Claim Construction Opening Brief served by 10/27/2021. Claim Construction Answering Brief served by 12/1/2021. Claim Construction Reply Brief served by 1/7/2022. Claim Construction Surreply Brief served by 1/28/2022. Joint Claim Construction Brief filed by 2/2/2022. A Markman Hearing is set for 3/4/2022 at 02:00 PM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 2/14/2023 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 2/27/2023 at 09:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 1/27/2021. (dlw)
Jan 22, 2021	25	Proposed Order (15) Docket Text: PROPOSED ORDER // Scheduling Order by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 1/25/2021 (dlw).
Jan 20, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [24] STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order to January 22, 2021. ORDERED by Judge Maryellen Noreika on 1/20/2021. (dlw)
Jan 19, 2021	24	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order to January 22, 2021 - filed by Apotex Corp., Apotex Inc.. (Belgam, Neal)
Jan 13, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED re (20 in 1:20-cv-01155-MN, 24 in 1:20-cv-01215-MN, 23 in 1:20-cv-01105-MN, 24 in 1:20-cv-01214-MN, 22 in 1:20-cv-01154-MN) MOTION for Pro Hac Vice Appearance of Attorney Douglas Behrens filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd., Intercept Pharma Europe LTD. ORDERED by Judge Maryellen Noreika on 1/13/2021. (dlw)
Jan 13, 2021	23	Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Douglas Behrens - filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe Ltd.. (Blumenfeld, Jack)
Jan 11, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED re (19 in 1:20-cv-01155-MN, 22 in 1:20-cv-01105-MN, 23 in 1:20-cv-01215-MN, 23 in 1:20-cv-01214-MN, 21 in 1:20-cv-01154-MN) STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order to January 19, 2021. ORDERED by Judge Maryellen Noreika on 1/11/2021. (dlw)
Jan 11, 2021	22	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Scheduling Order to January 19, 2021 - filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc.. (Tigan, Jeremy)
Dec 22, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED re (20 in 1:20-cv-01214-MN, 22 in 1:20-cv-01215-MN, 18 in 1:20-cv-01155-MN, 21 in 1:20-cv-01105-MN, 20 in 1:20-cv-01154-MN) STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to January 11, 2021. ORDERED by Judge Maryellen Noreika on 12/22/2020. (dlw)
Dec 22, 2020	21	Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to January 11, 2021 - filed by Intercept Pharma Europe Limited, Intercept Pharmaceuticals, Inc.. (Blumenfeld, Jack)
Dec 14, 2020	20	Answer to Counterclaim (25) Docket Text: ANSWER to [18] Answer to Amended Complaint, Counterclaim // Answer to Apotex's Counterclaims // by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. (Blumenfeld, Jack) Modified on 12/15/2020 (dlw).
Dec 1, 2020	N/A	Oral Order (0) Docket Text: ORAL ORDER - IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed, coordinated order, including a proposal for the length and timing of trial, to the Court no later than thirty (30) days from the date of this Order. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms). If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 12/1/2020. (dlw)
Nov 30, 2020	18	Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [15] Amended Complaint, and Separate Defenses, COUNTERCLAIM against Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. by Apotex Inc., Apotex Corp.(Ormerod, Eve) Modified on 12/1/2020 (dlw).
Nov 24, 2020	17	Answer to Counterclaim (21) Docket Text: ANSWER to [14] Answer to Complaint, Counterclaim // Answer to Apotex's First Amended Counterclaims by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.(Tigan, Jeremy) Modified on 11/25/2020 (dlw).
Nov 13, 2020	14	Main Document (43) Docket Text: Amended ANSWER to [1] Complaint, and Separate Defenses, COUNTERCLAIM against Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. by Apotex Corp., Apotex Inc. (Ormerod, Eve) Modified on 11/16/2020 (dlw). (Additional attachment(s) added on 11/16/2020: # (1) Redline Comparison) (dlw).
Nov 13, 2020	14	Redline Comparison (43)
Nov 13, 2020	15	Main Document (26) Docket Text: First AMENDED COMPLAINT against Apotex Corp., Apotex Inc.- filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Attachments: # (1) Exhibits A-F)(Blumenfeld, Jack) (Additional attachment(s) added on 11/16/2020: # (2) Redline Comparison) (dlw).
Nov 13, 2020	15	Exhibits A-F (513)
Nov 13, 2020	15	Redline Comparison (28)
Nov 13, 2020	16	Patent/Trademark Report to Commissioner (1) Docket Text: UPDATED Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 9,238,673 B2; 10,047,117 B2; 10,052,337 B2; 10,174,073 B2; 10,758,549 B2 (Blumenfeld, Jack) Modified on 11/16/2020 (dlw).
Nov 13, 2020	15	Amended Complaint* (1)
Oct 27, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Kevin M. Nelson, Sailesh K. Patel, Joel M. Wallace for Apotex Corp. and Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
Oct 26, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [12] MOTION for Pro Hac Vice Appearance of Attorney Kevin M. Nelson, Sailesh K. Patel, and Joel M. Wallace filed by Apotex Inc., Apotex Corp. ORDERED by Judge Maryellen Noreika on 10/26/2020. (dlw)
Oct 26, 2020	12	Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kevin M. Nelson, Sailesh K. Patel, and Joel M. Wallace - filed by Apotex Corp., Apotex Inc.. (Ormerod, Eve)
Oct 26, 2020	13	Notice (Other) (1) Docket Text: NOTICE of Appearance of Arun J. Mohan by Apotex Corp., Apotex Inc. (Ormerod, Eve)
Oct 23, 2020	10	Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Separate Defenses, COUNTERCLAIM against Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc. by Apotex Corp., Apotex Inc. (Belgam, Neal) Modified on 10/26/2020 (dlw).
Oct 23, 2020	11	Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceuticals Holdings Inc., Corporate Parent Apotex Holdings, Inc. for Apotex Inc.; Corporate Parent Apotex Holdings, Inc. for Apotex Corp. filed by Apotex Corp., Apotex Inc.. (Belgam, Neal)
Sep 1, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Mary Swears for Intercept Pharma Europe LTD., for Intercept Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Aug 28, 2020	8	Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe LTD.: For Apotex Corp. waiver sent on 8/28/2020, answer due 10/27/2020. (Blumenfeld, Jack)
Aug 28, 2020	9	Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe LTD.: For Apotex Inc. waiver sent on 8/28/2020, answer due 10/27/2020. (Blumenfeld, Jack)
Aug 27, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [7] MOTION for Pro Hac Vice Appearance of Attorney Christopher Sipes, Jeffrey B. Elikan, Megan Keane, Jeremy Cobb, Laura Dolbow, and Mary Swears filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe LTD. ORDERED by Judge Maryellen Noreika on 8/27/2020. (dlw)
Aug 27, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jeffrey B. Elikan for Intercept Pharma Europe LTD., for Intercept Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Aug 26, 2020	N/A	Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb)
Aug 25, 2020	7	Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher Sipes, Jeffrey B. Elikan, Megan Keane, Jeremy Cobb, Laura Dolbow, and Mary Swears - filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (Blumenfeld, Jack)
Aug 24, 2020	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. 7 deleted. Document was intended for a different case. (sam)
Aug 24, 2020	6	Main Document (2) Docket Text: Summonses Issued as to Apotex Corp. and Apotex Inc. (please complete the top portion of the form and print out for use/service). (Attachments: # (1) Summons- Apotex Corp)(sam)
Aug 24, 2020	6	Summons- Apotex Corp (2)
Aug 21, 2020	1	Main Document (21) Docket Text: COMPLAINT for Patent Infringement filed against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3146824.) - filed by Intercept Pharmaceuticals, Inc., Intercept Pharma Europe LTD.. (Attachments: # (1) Exhibit A-E, # (2) Civil Cover Sheet)(sam)
Aug 21, 2020	1	Exhibit A-E (406)
Aug 21, 2020	1	Civil Cover Sheet (1)
Aug 21, 2020	2	Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam)
Aug 21, 2020	3	Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673 B2 ;10,047,117 B2 ;10,052,337 B2 ;10,174,073 B2. (sam)
Aug 21, 2020	4	ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: not earlier than 07/13/2020. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/27/2023. (sam)
Aug 21, 2020	5	Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Intercept Pharma Europe LTD., Intercept Pharmaceuticals, Inc.. (sam)
Aug 21, 2020	1	Complaint* (1)

Lawsuits

Intercept Pharmaceuticals, Inc. et al v. Apotex Inc. et al > Documents